Showing results (21-30 of 117) with videos related to
Sort By:
Pageof 12
Journal of Inflammation Research|May 20, 2021
Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma PalpebrarumHsuan-Wei Chen, Jung-Chun Lin, Ying-Hsuen Wu, et al.Clinical and Translational Science|April 26, 2019
Models of Variability and Circadian Rhythm in Heart Rate, Blood Pressure, and QT Interval for Healthy Subjects Who Received Placebo in Phase I TrialsMukul Minocha, Hong Li, Yi-Lin Chiu, et al.Clinical Therapeutics|October 8, 2013
Exposure-response (safety) analysis to identify linifanib dose for a Phase III study in patients with hepatocellular carcinomaYi-Lin Chiu, Dawn M Carlson, Rajendra S Pradhan, et al.JPMA. the Journal of the Pakistan Medical Association|June 17, 2022
New insights into sex differences in primary biliary cholangitis. Gender difference in primary biliary cholangitisYing-Hsuen Wu, Yi-Lin Chiu, Jung-Chun Lin, et al.International Journal of Molecular Sciences|June 10, 2023
Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to TemozolomideShao-Wei Feng, Zih-Syuan Wu, Yi-Lin Chiu, et al.Pain Medicine (Malden, Mass.)|January 28, 2016
A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy AdultsMark Wallace, Rachel Duan, Wei Liu, et al.Digestive Diseases and Sciences|May 24, 2006
Presenting symptoms of nonerosive and erosive esophagitis in pediatric patientsSandeep K Gupta, Eric Hassall, Yi-Lin Chiu, et al.Clinical Pharmacology in Drug Development|May 21, 2016
A Phase 1 Study to Evaluate the Bioavailability and Food Effect of 2 Solid-Dispersion Formulations of the TRPV1 Antagonist ABT-102, Relative to the Oral Solution Formulation, in Healthy Human VolunteersAhmed A Othman, Howard Cheskin, Charles Locke, et al.Journal of Parkinson'S Disease|February 18, 2017
Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-CarbidopaAhmed A Othman, Matthew Rosebraugh, Krai Chatamra, et al.The AAPS Journal|July 8, 2017
Application of Exposure-Response Analyses to Establish the Pharmacodynamic Similarity of a Once-Daily Regimen to an Approved Twice-Daily Dosing Regimen for the Treatment of HCV InfectionAkshanth R Polepally, Haoyu Wang, Patrick J Marroum, et al.Pageof 12